The central venous catheter market in the United States is widely used for administering medications, blood products, total parenteral nutrition, or for long-term venous access. The catheters are made up of a soft plastic tube known as a catheter placed into large veins in the neck, chest, or groin to deliver fluids or medications. Central venous catheters help deliver medications and nutrients directly into large veins when oral administration is not possible. Catheters are needed for patients undergoing cancer treatments, surgeries, intensive care, or lifelong infusion therapies.
The U.S. central venous catheter market is estimated to be valued at US$ 1252.07 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period of 2024 to 2031.
Rising prevalence of chronic and life-threatening diseases such as cancer is a key factor driving market growth. According to the latest Centers for Disease Control and Prevention data, around 690,000 people in the U.S. die from heart disease annually while 600,000 die due to cancer. Growing geriatric population who are more susceptible to chronic diseases also supports market expansion.
Key Takeaways
Key players operating in the U.S. central venous catheter market are Robert Bosch GmbH, Continental AG, DENSO Corporation, HELLA GmbH, and Infineon Technologies AG. These companies collectively accounted for around 35% of the overall market share in 2024.
Some of the key opportunities in the market include development of advanced catheters integrated with sensors to reduce the risk of infection and thrombosis. For example, companies are developing catheters coated with antimicrobial substances like chlorhexidine and silver sulfadiazine. Catheters integrated with optical sensors and transducers to continuously monitor vital signs are also gaining popularity.
The U.S. central venous catheter market demand is witnessing strong growth in Asia Pacific and Middle East regions due to improving access to healthcare facilities and rising medical tourism. Several U.S. companies are expanding their product portfolio and building manufacturing plants in countries like India and China to leverage low costs and cater to the local market. For instance, Medtronic opened a new manufacturing facility in India in 2022 with investments of over $100 million.
Market Drivers
Rising prevalence of chronic diseases like cancer requiring long-term venous access is a key factor augmenting demand for central venous catheters. According to the American Cancer Society, there were an estimated 1.9 million new cancer cases diagnosed in the U.S. in 2022. This rising cancer incidence is expected to propel catheter sales.
Market Restraints
One of the major restraints is the risk of central line-associated bloodstream infections from catheter use that can increase patient recovery times and healthcare costs. Improper insertion and maintenance techniques may introduce pathogens into the bloodstream. Strict regulations have been implemented to curb infections which can hamper market potential.
Segment Analysis
The U.S. central venous catheter market can be segmented based on product type, design, end use and material. Among product types, peripherally inserted central catheters dominate the market as they provide easy and safe access to central veins. These catheters are preferred for chemotherapy and antibiotics administration as they reduce risks associated with other catheter types.
Global Analysis
Regionally, North America dominates the U.S. central venous catheter market and holds the largest share. High prevalence of chronic diseases coupled with growing geriatric population demanding frequent catheterization procedures drives the market in the region. Asia Pacific is the fastest growing market due to rising healthcare expenditure, increasing incidence of cancer and growing medical tourism industry. Developing economies like China and India are expected to boost the APAC central venous catheter market during the forecast period.
Get more insights on U.S. Central Venous Catheter Market
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.